Schneider, Henning

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2014 | 2011 | 2009 | 2008 | 2007 | 2006

2014

Jain, Arjun; Schneider, Henning; Aliyev, Eldar; Soydemir, Fatimah; Baumann, Marc Ulrich; Surbek, Daniel; Hediger, Matthias; Brownbill, Paul; Albrecht, Christiane (2014). Hypoxic treatment of human dual placental perfusion induces a preeclampsia-like inflammatory response. Laboratory investigation, 94(8), pp. 873-880. Nature Publishing Group 10.1038/labinvest.2014.76

Abumaree, M H; Brownbill, P; Burton, G; Castillo, C; Chamley, L; Croy, B A; Drewlo, S; Dunk, C; Girard, S; Hansson, S; Jones, S; Jurisicova, A; Lewis, R; Letarte, M; Parast, M; Pehrson, C; Rappolee, D; Schneider, Henning; Tannetta, D; Varmuza, S; ... (2014). IFPA Meeting 2013 Workshop Report III: maternal placental immunological interactions, novel determinants of trophoblast cell fate, dual ex vivo perfusion of the human placenta. Placenta, 35(Suppl), S15-S19. Elsevier 10.1016/j.placenta.2013.11.009

Cronqvist, Tina; Saljé, Karen; Familari, Mary; Guller, Seth; Schneider, Henning; Gardiner, Chris; Sargent, Ian L; Redman, Christopher W; Mörgelin, Matthias; Åkerström, Bo; Gram, Magnus; Hansson, Stefan R (2014). Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia. PLoS ONE, 9(2), e90020. Public Library of Science 10.1371/journal.pone.0090020

2011

Gobrecht, U; Raio, L; Mueller, MD; Schneider, H; Kuhn, A (2011). Postpartale Blasenretention: eine single center Analyse. In: Jahreskongress SGGG, Lugano 2011. Jahreskongress SGGG, Lugano 2011

2009

Schneider, H (2009). Tolerance of human placental tissue to severe hypoxia and its relevance for dual ex vivo perfusion. Placenta, 30 Suppl A, S71-S76. Amsterdam: Elsevier 10.1016/j.placenta.2008.11.004

Aufdenblatten, M; Baumann, M; Raio, L; Dick, B; Frey, BM; Schneider, H; Surbek, D; Hocher, B; Mohaupt, MG (2009). Prematurity is related to high placental cortisol in preeclampsia. Pediatric research, 65(2), pp. 198-202. New York, N.Y.: Nature Publishing Group 10.1203/PDR.0b013e31818d6c24

2008

Baumann, M; Bersinger, N; Mohaupt, M; Schneider, H; Surbek, D (2008). First trimester soluble endoglin and soluble fms-like tyrosine-kinase-1 levels for the prediction of pregnancies with subsequent pre-eclampsia. Reproductive sciences(15), 211A. Thousand Oaks, Calif.: Sage

2007

Di Santo, S; Sager, R; Andres, A-C; Guller, S; Schneider, H (2007). Dual in vitro perfusion of an isolated cotyledon as a model to study the implication of changes in the third trimester placenta on preeclampsia. Placenta, 28 Suppl A, S23-32. Amsterdam: Elsevier 10.1016/j.placenta.2007.01.009

Guller, S; Ma, Y; Malek, A; Di Santo, S; Schneider, H (2007). Differential release of plasminogen activator inhibitors (PAIs) during dual perfusion of human placenta: implications in preeclampsia. Placenta, 28(4), pp. 278-85. Amsterdam: Elsevier 10.1016/j.placenta.2006.05.005

2006

Chennakesava, C S; Di Santo, S; Ziemiecki, A; Schneider, H; Andres, A-C (2006). Differential expression of the receptor tyrosine kinase EphB4 and its ligand Ephrin-B2 during human placental development. Placenta, 27(9-10), pp. 959-67. Amsterdam: Elsevier 10.1016/j.placenta.2005.10.008

Provide Feedback